calendar
1,743 catalysts · 3,070 8k filing · 2,096 grant · 1,160 approval · 1,000 device adverse event · 874 device 510k · 623 device pma
1,743 catalysts · 3,070 8k filing · 2,096 grant · 1,160 approval · 1,000 device adverse event · 874 device 510k · 623 device pma
no tagged catalysts yet
Sponsor: GLAND. Form: SOLUTION/DROPS. Route: OPHTHALMIC
Sponsor: UPSHER SMITH LABS. Form: SUSPENSION/DROPS. Route: OTIC
Sponsor: HIKMA. Form: SOLUTION. Route: ORAL
Sponsor: HIKMA. Form: SOLUTION. Route: ORAL
Sponsor: HIKMA. Form: SOLUTION. Route: ORAL
Sponsor: HIKMA. Form: SOLUTION. Route: ORAL
Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL
Sponsor: VISTAPHARM LLC. Form: SOLUTION. Route: ORAL
Sponsor: VISTAPHARM LLC. Form: SOLUTION. Route: ORAL
Sponsor: VISTAPHARM LLC. Form: SOLUTION. Route: ORAL
Sponsor: VISTAPHARM LLC. Form: SOLUTION. Route: ORAL
Sponsor: SANALUZ. Form: TABLET. Route: ORAL
Sponsor: STRIDES PHARMA INTL. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL
Sponsor: RISING. Form: TABLET. Route: ORAL
Sponsor: NOVEL LABS INC. Form: SOLUTION. Route: ORAL
Sponsor: NOVEL LABS INC. Form: SOLUTION. Route: ORAL
Sponsor: NOVEL LABS INC. Form: SOLUTION. Route: ORAL
Sponsor: NOVEL LABS INC. Form: SOLUTION. Route: ORAL
Sponsor: SAREPTA THERAPS INC. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: GLAND. Form: POWDER. Route: INTRAVENOUS, SUBCUTANEOUS
Sponsor: KNACK. Form: INJECTABLE. Route: INJECTION
Sponsor: ELI LILLY AND CO. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: ELI LILLY AND CO. Form: SOLUTION. Route: SUBCUTANEOUS
Sponsor: ACCORD HLTHCARE. Form: TABLET. Route: ORAL
Sponsor: HEBEI CHANGSHAN. Form: INJECTABLE. Route: SUBCUTANEOUS
Sponsor: EPIC PHARMA LLC. Form: TABLET. Route: ORAL
Sponsor: BIOCON BIOLOGICS INC. Form: INJECTABLE. Route: INJECTION
Sponsor: HUMANWELL. Form: TABLET. Route: ORAL
Sponsor: HUMANWELL. Form: TABLET. Route: ORAL
Sponsor: MYLAN. Form: TABLET. Route: ORAL-28
Sponsor: MICRO LABS LTD INDIA. Form: TABLET. Route: ORAL
Sponsor: INNOGENIX. Form: TABLET. Route: ORAL
Sponsor: XCOVERY. Form: CAPSULE. Route: ORAL
Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL
Sponsor: ZYDUS LIFESCIENCES. Form: TABLET. Route: ORAL
Sponsor: STRIDES PHARMA. Form: TABLET. Route: ORAL
Sponsor: MICRO LABS. Form: POWDER. Route: ORAL
Sponsor: TORRENT. Form: TABLET, ORALLY DISINTEGRATING. Route: ORAL
Sponsor: BAXTER HLTHCARE CORP. Form: INJECTABLE. Route: INJECTION
Sponsor: FDC LTD. Form: TABLET. Route: ORAL
Sponsor: MICRO LABS. Form: INJECTABLE. Route: INJECTION
Sponsor: NOVEL LABS INC. Form: TABLET. Route: ORAL
Sponsor: EMERGENT. Form: SPRAY, METERED. Route: NASAL
Sponsor: ABHAI LLC. Form: SOLUTION. Route: ORAL
Sponsor: UNIQUE PHARM. Form: TABLET. Route: ORAL
Sponsor: UMEDICA. Form: TABLET. Route: ORAL
Sponsor: BIOCON PHARMA. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: ESPERION THERAPS INC. Form: TABLET. Route: ORAL
Sponsor: ESPERION THERAPS INC. Form: TABLET. Route: ORAL
Sponsor: SUNNY. Form: INJECTABLE. Route: INJECTION